KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioEBIT MarginEBITDA MarginEBT MarginEnterprise ValueFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on Invested CapitalReturn on SalesTimes Interest Earned

BioNTech SE (BNTX) Return on Invested Capital (2019 - 2025)

BioNTech SE's Return on Invested Capital history spans 7 years, with the latest figure at 0.01% for Q4 2025.

  • On a quarterly basis, Return on Invested Capital rose 2.0% to 0.01% in Q4 2025 year-over-year; TTM through Dec 2025 was 0.01%, a 2.0% increase, with the full-year FY2022 number at 0.01%, up 1.0% from a year prior.
  • Return on Invested Capital hit 0.01% in Q4 2025 for BioNTech SE, down from 0.01% in the prior quarter.
  • Over the last five years, Return on Invested Capital for BNTX hit a ceiling of 6938.33% in Q1 2021 and a floor of 0.03% in Q3 2024.
  • Historically, Return on Invested Capital has averaged 852.76% across 5 years, with a median of 0.01% in 2023.
  • Biggest five-year swings in Return on Invested Capital: surged 607820bps in 2021 and later tumbled -693832bps in 2022.
  • Tracing BNTX's Return on Invested Capital over 5 years: stood at 0.01% in 2021, then decreased by -24bps to 0.01% in 2022, then dropped by -11bps to 0.01% in 2023, then plummeted by -405bps to 0.03% in 2024, then soared by 59bps to 0.01% in 2025.
  • Business Quant data shows Return on Invested Capital for BNTX at 0.01% in Q4 2025, 0.01% in Q3 2025, and 0.01% in Q2 2025.